Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf^® within a pressurized metered dose inhaler: a Calu-3 model

References

• OnoueSMisakaSKawabataYYamadaSNew treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapyExpert Opin Drug Deliv20096879381119558334
   PubMed Web of Science ®Google Scholar
• HaghiMTrainiDYoungPIn vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalersPharm Res20143171779178724549816
   PubMed Web of Science ®Google Scholar
• OngHXTrainiDYoungPMPharmaceutical applications of the Calu-3 lung epithelia cell lineExpert Opin Drug Deliv20131091287130223730924
   PubMed Web of Science ®Google Scholar
• HarcourtJLHaynesLMEstablishing a liquid-covered culture of polar-ized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitroJ Vis Exp201372e50157
   PubMed Web of Science ®Google Scholar
• KesserKCGellerDENew aerosol delivery devices for cystic fibrosisRespir Care200954675476819467162
   PubMed Web of Science ®Google Scholar
• NewhouseMAdvantages of pressurized canister metered dose inhalersJ Aerosol Med19914313915010147675
   PubMedGoogle Scholar
• MeersPNevilleMMalininVBiofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infectionsJ Antimicrob Chemother200861485986818305202
   PubMed Web of Science ®Google Scholar
• BeijaMSalvayreRLauth-de ViguerieNMartyJColloidal systems for drug delivery: from design to therapyTrends Biotechnol201230948549622673692
   PubMed Web of Science ®Google Scholar
• ViljoenIThe Role of Surfactant in, and a Comparison of, the Permeability of Porcine and Human Epithelia to Various Chemical Compounds [dissertation]StellenboschUniversity of Stellenbosch2005
   Google Scholar
• InnovusSynsurf – synthetic lung surfactant Available from: http://www.innovus.co.za/technologies/medicine-and-health-1/therapeutics-and-pharmaceutics/synsurf-synthetic-lung-surfactant.htmlAccessed November 22, 2017
   Google Scholar
• van ZylJMSmithJSurfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactantDrug Design Dev Ther20137905916
   PubMed Web of Science ®Google Scholar
• DekaliSGamezCKortulewskiTBlazyKRatPLacroixGAssessment of an in vitro model of pulmonary barrier to study the translocation of nanoparticlesToxicol Rep2014115717128962236
   PubMedGoogle Scholar
• Van ZylJMSmithJHawtreyAThe effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletionDrug Design Dev Ther20137139148
   PubMed Web of Science ®Google Scholar
• FischerERHansenBTNairVHoytFHDorwardDWScanning electron microscopyCurr Protoc Microbiol2012 Chapter 2:Unit2B.2
   PubMedGoogle Scholar
• HaghiMYoungPMTrainiDJaiswalRGongJBebawyMTime-and passage-dependent characteristics of a Calu-3 respiratory epithelial cell modelDrug Dev Ind Pharm201036101207121420374185
   PubMed Web of Science ®Google Scholar
• Copley ScientificIntroduction to Aerodynamic Particle Sizing Available from: http://issuu.com/pyramidpress/docs/inhaler_brochure_2015_rev4__high_re?e=6944369/13992727Accessed May 15, 2017
   Google Scholar
• HaghiMTrainiDPostmaDSBebawyMYoungPMFluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhalerRespirology20131881197120123796052
   PubMed Web of Science ®Google Scholar
• ProctorVKSignalling Pathways Linking Interleukin 13 Receptor Activation to Lung Epithelial Cell Function [dissertation]BathUniversity of Bath2013
   Google Scholar
• MathiasNRTimoszykJStetskoPIMegillJRSmithRLWallDAPermeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in ratsJ Drug Target2002101314011996084
   PubMed Web of Science ®Google Scholar
• HilgersARConradiRABurtonPSCaco-2 cell monolayers as a model for drug transport across the intestinal mucosaPharm Res1990799029102235888
   PubMed Web of Science ®Google Scholar
• SunHPangKSPermeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical studyDrug Metab Dispos200736110212317932224
   PubMed Web of Science ®Google Scholar
• FosterKAAveryMLYazdanianMAudusKLCharacterization of the Calu-3 cell line as a tool to screen pulmonary drug deliveryInt J Pharm2000208111111064206
   PubMed Web of Science ®Google Scholar
• ChampionJAKatareYKMitragotriSParticle shape: a new design parameter for micro- and nanoscale drug delivery carriersJ Control Release200712113917544538
   PubMed Web of Science ®Google Scholar
• SimoneEADziublaTDMuzykantovVRPolymeric carriers: role of geometry in drug deliveryExp Opin Drug Deliv200851212831300
   PubMed Web of Science ®Google Scholar
• YooJWDoshiNMitragotriSAdaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug deliveryAdv Drug Deliv Rev201163141247125621605607
   PubMed Web of Science ®Google Scholar
• KimDKDobsonJNanomedicine for targeted drug deliveryJ Mater Chem2009193562946307
   Web of Science ®Google Scholar
• VenkataramanSHedrickJLOngZYThe effects of polymeric nanostructure shape on drug deliveryAdv Drug Deliv Rev201163141228124621777633
   PubMed Web of Science ®Google Scholar
• LuJHouRYangZTangZDevelopment and characterization of drug-loaded biodegradable PLA microcarriers prepared by the electrospraying technique (poly(L-lactide)) (report)Int J Mol Med201536124925425955135
   PubMed Web of Science ®Google Scholar
• AraiNYoshimotoYYasuokaKEbisuzakiTSelf-assembly behaviours of primitive and modern lipid membrane solutions: a coarse-grained molecular simulation studyPhys Chem Chem Phys20161828194261943227378100
   PubMed Web of Science ®Google Scholar
• BlankFRothen-RutishauserBMSchurchSGehrPAn optimized in vitro model of the respiratory tract wall to study particle cell interactionsJ Aerosol Med200619339240517034314
   PubMedGoogle Scholar
• MeindlCStranzingerSDzidicNPermeation of therapeutic drugs in different formulations across the airway epithelium in vitroPLoS One2015108e013569026274590
   PubMed Web of Science ®Google Scholar
• ZanenPGoLTLammersJOptimal particle size for β2 agonist and anticholinergic aerosols in patients with severe airflow obstructionThorax199651109779808977595
   PubMed Web of Science ®Google Scholar
• LabirisNRDolovichMBPulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsBr J Clin Pharmacol200356660061214616419
   PubMed Web of Science ®Google Scholar
• ZuoYYVeldhuizenRAWNeumannAWPetersenNOPos-smayerFCurrent perspectives in pulmonary surfactant – inhibition, enhancement and evaluationBiochim Biophys Acta20081778101947197718433715
   PubMed Web of Science ®Google Scholar
• TanevaSKeoughKMCholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air–water interfaceBiochemistry19973649129229020791
   PubMed Web of Science ®Google Scholar
• LevineMEnsomMHPost hoc power analysis: an idea whose time has passed?Pharmacotherapy200121440540911310512
   PubMed Web of Science ®Google Scholar